New crystalline polymorph form III of glimepiride having specific characteristics X-ray diffraction peaks, for used as an anti-diabetic medication for treating type 2 diabetes mellitus
	PANANDIKAR A M; MAHAJAN D R; GOSAR A N; NADAR S S; JADHAV S V
	2023-08-03
专利权人	INDOCO REMEDIES LTD (INDO-Non-standard)
申请日期	2023-08-03
专利号	IN202321052135-A
成果简介	NOVELTY - Crystalline polymorph form III of glimepiride having characteristics X-ray diffraction peaks at 3.47, 6.72, 13.45, 14.65, 15.99, 16.27, 19.69, 20.21, 21.25, 24.76, 25.32, 26.03, 27.07, 28.57, 30.15, 30.59, 32.26, 36.38, 36.84, 37.51, 38.11, 39.68 ± 0.2° 2θ is new. USE - Crystalline polymorph form III of glimepiride for used as an anti-diabetic medication for treating type 2 diabetes mellitus. No biological data given. ADVANTAGE - The Crystalline polymorph form III of glimepiride is consistently reproducible, does not have the tendency to convert to other forms, and found to be more stable at ambient storage conditions, temperature and at elevated temperatures. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for a method for preparation of Crystalline polymorph form III of glimepiride.
IPC 分类号	A61K-031/4015 ; C07D-207/38
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/20987
专题	中国科学院新疆生态与地理研究所
作者单位	INDOCO REMEDIES LTD (INDO-Non-standard)
推荐引用方式 GB/T 7714	PANANDIKAR A M,MAHAJAN D R,GOSAR A N,et al. New crystalline polymorph form III of glimepiride having specific characteristics X-ray diffraction peaks, for used as an anti-diabetic medication for treating type 2 diabetes mellitus. IN202321052135-A[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。